EV Biologics, Inc. (OTCMKTS:YECO – Get Free Report)’s share price shot up 16.7% during trading on Tuesday . The stock traded as high as $0.25 and last traded at $0.25. 500 shares traded hands during mid-day trading, an increase of 82% from the average session volume of 275 shares. The stock had previously closed at $0.21.
EV Biologics Stock Performance
The company has a fifty day moving average price of $0.25 and a two-hundred day moving average price of $0.32.
About EV Biologics
EV Biologics, Inc, a biotechnology company, engages in the commercial development of extracellular vesicles (EVs) as biological modalities for diagnostics and therapeutics. It is involved in developing vaccines, therapeutics, and cures based on its proprietary multifunctional EV platform. The company also focuses on developing human mesenchymal and other stem cell, and cell-derived products to market in the cosmetic and biopharmaceutical spaces.
See Also
- Five stocks we like better than EV Biologics
- The 3 Best Fintech Stocks to Buy Now
- Super Micro Computer Soars 28%: Is It Really Out of the Woods?
- Investing in Commodities: What Are They? How to Invest in Them
- Traders Are Flocking Back to Oil: What’s Fueling the Optimism
- Best Stocks Under $10.00
- 3 Hot Stock Trends to Ride Into 2025
Receive News & Ratings for EV Biologics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EV Biologics and related companies with MarketBeat.com's FREE daily email newsletter.
